-
公开(公告)号:EP1370169A4
公开(公告)日:2007-04-18
申请号:EP02717442
申请日:2002-02-15
Applicant: BAXTER INT
Inventor: HURST WILLIAM S , SMITH SIDNEY T , CALOZ PIERRE , RAMACHANDRAN SINDHU , ULM MICHELE M , RODRIGUEZ JESSE F
CPC classification number: B65B69/0091 , B65D77/061 , B65D90/205
Abstract: A container (10) having a plurality of panels (12-18) joined together to form a sleeve (64). The panels (12-18) each have an end edge that cooperate to define an imaginary plane (P) at one end of the sleeve (64). The container (10) further has an end panel (20,22) connected to the panels (12-18) at the one end of the sleeve (64). The end panel (20,22) has at least one portion extending beyond the imaginary plane (P). The supporting box (100) is provided to support the container (10). A hanger system (150) is provided and is attached to the box (100). The hanger system (150) supports an upper portion of the container (10) within the box (100). The container (10) is also provided with a port closure (300) that provides both a sterile and gas permeable barrier.
-
公开(公告)号:AU2013204469A1
公开(公告)日:2013-05-09
申请号:AU2013204469
申请日:2013-04-12
Applicant: BAXTER INT , BAXTER HEALTHCARE SA
Inventor: MIN KYUNGYOON , BACKES LARRY , RAUSA III FRANCISCO M , BAIRSTOW SHAWN F , RAMACHANDRAN SINDHU , POKROPINSKI SHARON
Abstract: A system for obtaining a pharmaceuticaly acceptable immunoglobulin product from blood of a donor including a first conduit configured to convey blood or blood component from the donor to a substrate, wherein said blood or blood component includes at least one first component and at least one second component, said first component inckding immunoglobulin, and wherein said substrate is adapted to bind immunoglobulin; a second condL it configured to convey at least a portion of the second component of the blood or blood component from the first conduit to the donor; a third conduit configured to convey an immunoglobulin product isolated frm said substrate; and a fourth conduit configured to convey the product directly to a recipient
-
公开(公告)号:CA2806645A1
公开(公告)日:2012-01-26
申请号:CA2806645
申请日:2011-07-22
Applicant: BAXTER INT , BAXTER HEALTHCARE SA
Inventor: BAIRSTOW SHAWN F , HUTSELL JENNIFER , RAMACHANDRAN SINDHU
IPC: C07K14/81
Abstract: The present invention provides compositions and pharmaceutical formulations of lalp derived from plasma. Also provided are methods for the manufacture of the lalp compositions and formulations, as well as method for the treatment of diseases associated with lalp dysfunction.
-
公开(公告)号:AU2006207865A1
公开(公告)日:2006-09-28
申请号:AU2006207865
申请日:2006-09-06
Applicant: BAXTER INT
Inventor: CALOZ PIERRE , RAMACHANDRAN SINDHU , ULM MICHELE M , SMITH SIDNEY T , RODRIGUEZ JESSE F , HURST WILLIAM S
-
公开(公告)号:CO6680653A2
公开(公告)日:2013-05-31
申请号:CO13035387
申请日:2013-02-21
Applicant: BAXTER INT , BAXTER HEALTHCARE SA
Inventor: BAIRSTOW SHAWN F , HUTSELL JENNIFER , RAMACHANDRAN SINDHU
IPC: C07K14/81
Abstract: La presente invención proporciona las composiciones y formulaciones farmacéuticas de lalp derivada del plasma. Se proporciona además la fabricación de las composiciones y formulaciones de lalp, así como el método para el tratamiento de las enfermedades asociadas con la disfunción de lalp.Un método para preparar una composición de lalp enriquecida a partir de plasma, el método comprende las etapas de: (a) proporcionar una fracción de plasma crio-pobre; (b) precipitar lalp de la fracción de plasma crio-pobre con al menos una primera reacción de precipitación con etanol para formar un precipitado que contiene lalp; y (c) extraer lalp del precipitado que contiene IaIp, formando de ese modo una composición de lalp enriquecida; en donde él precipitado de lalp se selecciona del grupo que consiste de una torta de filtro de la Fracción II+III, un precipitado de la Fracción I, un precipitado de la Fracción I+II+III, un precipitado de la Fracción II+III, Fracción IV-1, un precipitado A de Kistler-Nitschmann, y un precipitado B de Kistler-Nitschmann.Métodos para la co-fabricación de lalp y Factor H a partir de fraccionamientos de plasma desechados de cualquier otra forma durante la fabricación de otras composiciones de factor de la sangre.
-
公开(公告)号:MX2011006608A
公开(公告)日:2011-07-12
申请号:MX2011006608
申请日:2009-12-18
Applicant: BAXTER INT
Inventor: MIN KYUNGYOON , BACKLES LARRY , RAUSA FRANCISCO M III , BAIRSTOW SHAWN F , RAMACHANDRAN SINDHU , POKROPINSKI SHARON
Abstract: La presente descripción se refiere en general a sistemas para obtener una inmunoglobulina farmacéuticamente aceptable a partir de sangre de un donador, que comprenden un primer conducto configurado para transportar sangre del donador a un substrato, en donde dicha sangre incluye al menos un primer componente y al menos un segundo componente, dicho primer componente de la sangre incluyendo inmunoglobulina, y en donde dicho substrato está adaptado para unir inmunoglobulina; y un segundo conducto configurado para transportar al menos una porción del segundo componente de la sangre a partir del primer conducto hacia el donador.
-
公开(公告)号:CA2615661A1
公开(公告)日:2002-09-26
申请号:CA2615661
申请日:2002-02-15
Applicant: BAXTER INT
Inventor: HURST WILLIAM S , SMITH SIDNEY T , ULM MICHELE M , RAMACHANDRAN SINDHU , CALOZ PIERRE , RODRIGUEZ JESSE F
Abstract: A hanger system for supporting a flexible medical container in a support container, comprises a support member adapted to be connected to a top portion of the support container and a hanger having a plurality of depending members adapted to be connected to the flexible container. The hanger is connected to the support member.
-
公开(公告)号:CA2441047A1
公开(公告)日:2002-09-26
申请号:CA2441047
申请日:2002-02-15
Applicant: BAXTER INT
Inventor: HURST WILLIAM S , RODRIGUEZ JESSE F , SMITH SIDNEY T , ULM MICHELE M , CALOZ PIERRE , RAMACHANDRAN SINDHU
Abstract: A container (10) having a plurality of panels (12-18) joined together to for m a sleeve (64). The panels (12-18) each have an end edge that cooperate to define an imaginary plane (P) at one end of the sleeve (64). The container (10) further has an end panel (20,22) connected to the panels (12-18) at the one end of the sleeve (64). The end panel (20,22) has at least one portion extending beyond the imaginary plane (P). The supporting box (100) is provid ed to support the container (10). A hanger system (150) is provided and is attached to the box (100). The hanger system (150) supports an upper portion of the container (10) within the box (100). The container (10) is also provided with a port closure (300) that provides both a sterile and gas permeable barrier.
-
公开(公告)号:AU2011280907A1
公开(公告)日:2013-02-07
申请号:AU2011280907
申请日:2011-07-22
Applicant: BAXTER INT , BAXTER HEALTHCARE SA
Inventor: BAIRSTOW SHAWN F , HUTSELL JENNIFER , RAMACHANDRAN SINDHU
IPC: C07K14/81
Abstract: The present invention provides compositions and pharmaceutical formulations of lalp derived from plasma. Also provided are methods for the manufacture of the lalp compositions and formulations, as well as method for the treatment of diseases associated with lalp dysfunction.
-
公开(公告)号:CA2441047C
公开(公告)日:2008-04-29
申请号:CA2441047
申请日:2002-02-15
Applicant: BAXTER INT
Inventor: HURST WILLIAM S , SMITH SIDNEY T , CALOZ PIERRE , RAMACHANDRAN SINDHU , ULM MICHELE M , RODRIGUEZ JESSE F
Abstract: A container (10) having a plurality of panels (12-18) joined together to for m a sleeve (64). The panels (12-18) each have an end edge that cooperate to define an imaginary plane (P) at one end of the sleeve (64). The container (10) further has an end panel (20,22) connected to the panels (12-18) at the one end of the sleeve (64). The end panel (20,22) has at least one portion extending beyond the imaginary plane (P). The supporting box (100) is provid ed to support the container (10). A hanger system (150) is provided and is attached to the box (100). The hanger system (150) supports an upper portion of the container (10) within the box (100). The container (10) is also provided with a port closure (300) that provides both a sterile and gas permeable barrier.
-
-
-
-
-
-
-
-
-